ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,818,000 | -54.3% | 129,000 | -21.4% | 0.21% | +91.1% |
| Q1 2022 | $3,974,000 | +5.7% | 164,037 | +1.9% | 0.11% | +47.4% |
| Q4 2021 | $3,758,000 | +1409.2% | 161,000 | +973.3% | 0.08% | +850.0% |
| Q3 2021 | $249,000 | -91.3% | 15,000 | -86.5% | 0.01% | -88.7% |
| Q1 2021 | $2,866,000 | +1333.0% | 111,100 | +1381.3% | 0.07% | +222.7% |
| Q2 2019 | $200,000 | -0.5% | 7,500 | 0.0% | 0.02% | +10.0% |
| Q1 2019 | $201,000 | – | 7,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |